- Home
- SLAB vs CRNX Comparison
SLAB vs CRNX Comparison
Compare SLAB & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLAB
- CRNX
- Stock Information
- Founded
- SLAB 1996
- CRNX 2008
- Country
- SLAB United States
- CRNX United States
- Employees
- SLAB N/A
- CRNX N/A
- Industry
- SLAB Semiconductors
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- SLAB Technology
- CRNX Health Care
- Exchange
- SLAB Nasdaq
- CRNX Nasdaq
- Market Cap
- SLAB 4.0B
- CRNX 4.1B
- IPO Year
- SLAB 2000
- CRNX 2018
- Fundamental
- Price
- SLAB $122.98
- CRNX $44.73
- Analyst Decision
- SLAB Buy
- CRNX Buy
- Analyst Count
- SLAB 10
- CRNX 11
- Target Price
- SLAB $144.90
- CRNX $71.00
- AVG Volume (30 Days)
- SLAB 295.0K
- CRNX 1.5M
- Earning Date
- SLAB 11-04-2025
- CRNX 11-06-2025
- Dividend Yield
- SLAB N/A
- CRNX N/A
- EPS Growth
- SLAB N/A
- CRNX N/A
- EPS
- SLAB N/A
- CRNX N/A
- Revenue
- SLAB $742,807,000.00
- CRNX $1,535,000.00
- Revenue This Year
- SLAB $37.60
- CRNX $405.68
- Revenue Next Year
- SLAB $19.26
- CRNX $1,034.87
- P/E Ratio
- SLAB N/A
- CRNX N/A
- Revenue Growth
- SLAB 47.10
- CRNX 47.74
- 52 Week Low
- SLAB $82.82
- CRNX $24.10
- 52 Week High
- SLAB $160.00
- CRNX $60.34
- Technical
- Relative Strength Index (RSI)
- SLAB 45.99
- CRNX 58.89
- Support Level
- SLAB $115.51
- CRNX $41.51
- Resistance Level
- SLAB $123.83
- CRNX $45.16
- Average True Range (ATR)
- SLAB 4.52
- CRNX 2.05
- MACD
- SLAB -0.16
- CRNX 0.08
- Stochastic Oscillator
- SLAB 44.41
- CRNX 93.77
About SLAB Silicon Laboratories Inc.
Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.